Evidence map›Paper›PMID 39894500›Full record

ReviewInternal medicine (Tokyo, Japan)2025

Simultaneous Presentation of Minimal Change Disease and Tubulointerstitial Nephritis Associated with Primary Sjögren's Syndrome and Hashimoto's Thyroiditis.

Tomohisa Tsuyuki, Mineaki Kitamura, Miho Takatani, Kiyokazu Tsuji, Kenta Torigoe, Sosuke Tsuji, Naruhiro Fujita, Yutaka Yamaguchi, Hiroshi Mukae, Tomoya Nishino

Abstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tomohisa TsuyukiDepartment of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Mineaki KitamuraDepartment of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Miho TakataniDepartment of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Kiyokazu TsujiDepartment of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Kenta TorigoeDepartment of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Sosuke TsujiDepartment of Rheumatology, Nagasaki Genbaku Hospital, Japan.
Naruhiro FujitaDepartment of Endocrinology, Nagasaki Genbaku Hospital, Japan.
Yutaka YamaguchiYamaguchi's Pathology Laboratory, Japan.
Hiroshi MukaeDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Tomoya NishinoDepartment of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 78-year-old woman experienced systemic edema and was diagnosed with nephrotic syndrome and Hashimoto's thyroiditis (HT). A renal biopsy revealed minimal change disease (MCD) and tubulointerstitial nephritis, which resulted in the diagnosis of primary Sjögren's syndrome (PSS). PSS and HT can be complicated with MCD; however, there are no published case reports of MCD presenting with both conditions simultaneously. We aimed to inform nephrologists and rheumatologists about this rare condition through a literature review of renal outcomes in patients with MCD associated with PSS and HT.

Indexed as

Hashimoto DiseaseNephritis, InterstitialNephrosis, LipoidSjogren's SyndromeAgedFemaleHumansHashimoto's thyroiditisminimal change diseaseSjögren's syndrometubulointerstitial nephritis

Identifiers

PMID39894500
PMCPMC12393951

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.